HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Vein Graft Disease

Vein Graft Disease

Vein graft disease is a condition that often arises after coronary artery bypass surgery, where a vein from the patient's leg is used to create a bypass around a blocked coronary artery. Over time, these grafts can undergo pathological changes, leading to the development of vein graft disease. The process involves a series of complex events, including inflammation, oxidative stress, and the formation of atherosclerotic plaques within the graft. As vein graft disease progresses, it can compromise blood flow to the heart, ultimately impacting the success of the bypass procedure. Researchers and clinicians focus on understanding the molecular and cellular mechanisms underlying vein graft disease to develop strategies for prevention and intervention, aiming to improve the long-term outcomes of coronary artery bypass grafting procedures.

Committee Members
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Heart Congress 2027 Speakers
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Speaker at International Heart Congress 2027 - Uwe Peter Tigor

Uwe Peter Tigor

Auxilius Pharma, United States

Submit your abstract Today

Watsapp